SEC Form 4 · accession 0000899243-16-012289
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Barrett
Director · 10% Owner
Period of report
Jan 25, 2016
Accepted (ET)
Jan 27, 2016 · 9:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 25, 2016 | A | 8,849 | $7.91 | A | 4,643,327 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities were issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Restricted Stock Agreement and the restrictions lapse over a period of one year starting January 1, 2016 on a quarterly basis in arrears.
- F2The Reporting Person previously reported 5,632,730 shares directly held by Atlas Venture Fund VII, L.P. ("Atlas Venture"). On March 24, 2015, Atlas Venture distributed in-kind 1,000,000 shares pro rata to its limited partners. The Reporting Person now reports 4,632,730 shares directly held by Atlas Venture and disclaims beneficial ownership of all such shares except to the extent of his pecuniary interest, if any, therein.